You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diffuse Midline Glioma

Showing 1 - 25 of 2,612
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,

Recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Hypofractionated Radiation Therapy
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Glioma Trial run by the National Cancer Institute (NCI) (pre-operative abemaciclib, Device for Cerebral Fluid Dialysate

Recruiting
  • Glioma
  • pre-operative abemaciclib
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Etoposide; Oral, 50 Mg
  • Focused ultrasound with neuro-navigator-controlled sonication
  • New York, New York
    Columbia University Irving Medical Center
Feb 28, 2023

Diffuse Midline Glioma, H3 K27M-Mutant Trial (GD2 CAR T cells)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • GD2 CAR T cells
  • (no location specified)
Sep 15, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

xPedite: A Study to Expedite DIPG and DMG Research

Not yet recruiting
  • Oncology
  • +2 more
    • Los Altos, California
      xCures, Inc.
    Nov 20, 2023

    Glioma of Spinal Cord, Glioma of Brainstem Trial in Stanford (GD2 CAR T cells, Fludarabine, Cyclophosphamide)

    Recruiting
    • Glioma of Spinal Cord
    • Glioma of Brainstem
    • GD2 CAR T cells
    • +2 more
    • Stanford, California
      Lucile Packard Children's Hospital (LPCH)
    Jun 22, 2022

    Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York

    Active, not recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +2 more
    • Panobinostat 15 MG
    • Focused Ultrasound with neuro-navigator-controlled sonication
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Feb 3, 2022

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)

    Not yet recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Jul 27, 2022

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • rHSC-DIPGVax
    • +2 more
    • Orange, California
    • +2 more
    Nov 10, 2022

    Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

    Recruiting
    • Diffuse Midline Glioma (DMG)
    • +7 more
    • ONC206
    • Standard of Care Radiation Therapy
    • San Francisco, California
    • +2 more
    Sep 13, 2022

    Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)

    Active, not recruiting
    • Glioblastoma
    • +5 more
    • Los Angeles, California
    • +4 more
    Apr 8, 2022

    Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)

    Completed
    • Brain and Central Nervous System Tumors
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jan 13, 2023

    Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma Trial in New York (Infusate with

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +2 more
    • Infusate with MTX110 and gadolinium
    • Convection-Enhanced Delivery (CED)
    • New York, New York
      Columbia University Irving Medical Center
    Mar 8, 2022

    Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M

    Not yet recruiting
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • San Francisco, California
      University of California, San Francisco
    Aug 15, 2022

    International Diffuse Intrinsic Pontine Glioma/Diffuse Midline

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +2 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Jun 18, 2021

      CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

      Not yet recruiting
      • Central Nervous System Neoplasms
      • +6 more
      • B7-H3-CAR T cells
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Apr 18, 2023

      Brain Tumor, Pediatric, Medulloblastoma, Childhood, Embryonal Tumor Trial (GD2-CART01 (iC9-GD2-CAR T-cells))

      Not yet recruiting
      • Brain Tumor, Pediatric
      • +6 more
      • GD2-CART01 (iC9-GD2-CAR T-cells)
      • (no location specified)
      Mar 18, 2022

      Targeted Pediatric High-Grade Glioma Therapy

      Not yet recruiting
      • High Grade Glioma
      • +8 more
        • Aurora, Colorado
        • +17 more
        May 1, 2023

        Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

        Recruiting
        • Cancer
        • +18 more
        • Houston, Texas
          MD Anderson Cancer Center
        Aug 12, 2022

        High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

        Not yet recruiting
        • High Grade Glioma
        • +8 more
        • Aurora, Colorado
        • +17 more
        May 2, 2023

        Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)

        Not yet recruiting
        • Glioma
        • +12 more
        • Observational
        • (no location specified)
        Feb 17, 2022

        CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

        Recruiting
        • Central Nervous System Neoplasms
        • +22 more
        • Bethesda, Maryland
          National Institutes of Health
        Mar 1, 2022